Financials

News Ideas Discussions Technicals Seasonals

LIXT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Lixte Biotechnology Holdings, Inc.

Total assets of LIXT for Q2 24 is 2.67 M USD, 25.68% less than the previous Q1 24. And total liabilities decreased by 8.94% in Q2 24 to 421.46 k USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—